Registration statement for securities of certain foreign private issuers

Research and Development Expenses

v3.19.3.a.u2
Research and Development Expenses
12 Months Ended
Dec. 31, 2018
Research and Development Expenses [Abstract]  
RESEARCH AND DEVELOPMENT EXPENSES

NOTE 13:- RESEARCH AND DEVELOPMENT EXPENSES

 

   

Year ended

December 31,

 
    2018     2017     2016  
    USD  
                   
Clinical and preclinical trials   $ 4,768     $ 3,809     $ 5,104  
Salary and related expenses     909       888       664  
Patents     229       234       198  
Royalties     14       11       11  
Laboratory materials     73       63       38  
Rent     51       51       48  
Depreciation     3       3       4  
Others     28       47       48  
                         
    $ 6,075     $ 5,106     $ 6,115